HETERO LABS LTD III FDA Approval ANDA 091475

ANDA 091475

HETERO LABS LTD III

FDA Drug Application

Application #091475

Documents

Letter2012-05-31

Application Sponsors

ANDA 091475HETERO LABS LTD III

Marketing Status

None (Tentative Approval)001

Application Products

001SOLUTION; ORAL10MG/ML0LAMIVUDINELAMIVUDINE

FDA Submissions

ORIG1TA2012-05-29

Submissions Property Types

ORIG1Null1

CDER Filings

HETERO LABS LTD III
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91475
            [companyName] => HETERO LABS LTD III
            [docInserts] => ["",""]
            [products] => [{"drugName":"LAMIVUDINE","activeIngredients":"LAMIVUDINE","strength":"10MG\/ML","dosageForm":"SOLUTION; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LAMIVUDINE","submission":"LAMIVUDINE","actionType":"10MG\/ML","submissionClassification":"SOLUTION; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.